ES2062502T3 - Una proteina de factor i pura y un procedimiento para obtener dicha proteina. - Google Patents

Una proteina de factor i pura y un procedimiento para obtener dicha proteina.

Info

Publication number
ES2062502T3
ES2062502T3 ES90900763T ES90900763T ES2062502T3 ES 2062502 T3 ES2062502 T3 ES 2062502T3 ES 90900763 T ES90900763 T ES 90900763T ES 90900763 T ES90900763 T ES 90900763T ES 2062502 T3 ES2062502 T3 ES 2062502T3
Authority
ES
Spain
Prior art keywords
protein
factor
pct
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90900763T
Other languages
English (en)
Inventor
E Karina Stergaard Als
Jesper Kihl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2062502T3 publication Critical patent/ES2062502T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

UNA PROTEINA DE FACTOR I PARA ESENCIALMENTE LIBRE DE VIRUS INFECCIOSO, FACTOR B Y C3. LA PROTEINA SE DERIVA DE PLASMA Y SE PASTERIZA CALENTANDOSE A UNA TEMPERATURA QUE OSCILE ENTRE 50 Y 65 C DURANTE 0.5 A 100 HORAS EN PRESENCIA DE UNO O MAS ESTABILIZADORES PARA FACTOR I. LOS PREPARADOS QUE CONTIENEN LA PROTEINA SON UTILES EN EL TRATAMIENTO DE DEFICIENCIA DE FACTOR I Y ENFERMEDADES AUTOINMUNOLOGICAS.
ES90900763T 1988-12-20 1989-12-19 Una proteina de factor i pura y un procedimiento para obtener dicha proteina. Expired - Lifetime ES2062502T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK708488A DK708488D0 (da) 1988-12-20 1988-12-20 Faktor i praeparat

Publications (1)

Publication Number Publication Date
ES2062502T3 true ES2062502T3 (es) 1994-12-16

Family

ID=8149208

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90900763T Expired - Lifetime ES2062502T3 (es) 1988-12-20 1989-12-19 Una proteina de factor i pura y un procedimiento para obtener dicha proteina.

Country Status (11)

Country Link
US (1) US5378811A (es)
EP (1) EP0449897B1 (es)
JP (1) JPH04502324A (es)
AT (1) ATE101521T1 (es)
AU (1) AU4811290A (es)
DE (1) DE68913212T2 (es)
DK (2) DK708488D0 (es)
ES (1) ES2062502T3 (es)
FI (1) FI95440C (es)
NO (1) NO912387D0 (es)
WO (1) WO1990006759A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
PT1107807E (pt) * 1998-08-25 2007-01-31 Ash Access Technology Inc Uso de um sal citrato numa solução de enchimento de cateter
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
GB0904427D0 (en) 2009-03-13 2009-04-29 Lachmann Peter Treatment of diseases related to hyperactivity of the complement system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤

Also Published As

Publication number Publication date
NO912387L (no) 1991-06-19
FI95440B (fi) 1995-10-31
JPH04502324A (ja) 1992-04-23
DK105391A (da) 1991-06-03
DK708488D0 (da) 1988-12-20
NO912387D0 (no) 1991-06-19
AU4811290A (en) 1990-07-10
WO1990006759A1 (en) 1990-06-28
EP0449897B1 (en) 1994-02-16
DK105391D0 (da) 1991-06-03
FI95440C (fi) 1996-02-12
EP0449897A1 (en) 1991-10-09
DE68913212T2 (de) 1994-05-19
DE68913212D1 (de) 1994-03-24
ATE101521T1 (de) 1994-03-15
US5378811A (en) 1995-01-03
FI912879A0 (fi) 1991-06-14

Similar Documents

Publication Publication Date Title
DE3750422T2 (de) Translation von mrna.
ES548048A0 (es) Un procedimiento para la preparacion de derivados purificados de una glicoproteina.
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
ES2082003T3 (es) Deshidrodidemnina b.
DE3787842D1 (de) Mittel zur Behandlung von Arthrosen.
DK0865294T3 (da) Fremgangsmåder til reduktion eller bibeholdelse af reducerede niveauer afblodlipider under anvendelse af OB-proteinpræparater
NO873699L (no) Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser.
SE8902532D0 (sv) Bestaemning av plasmaproteiner
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
ES2062502T3 (es) Una proteina de factor i pura y un procedimiento para obtener dicha proteina.
DE69131253D1 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
HUP9901161A2 (hu) Módosított aktivitású hibrid VIII. faktor
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE59109261D1 (de) Von proteinen des hepatitis c-virus abgeleitete polypeptide und deren verwendung
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69132682D1 (de) Zellwachstumsinhibitoren
ES2052482T1 (es) Inhibidora de la proliferacion de celulas endoteliales.
ES2032812T3 (es) Vacuna.
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 449897

Country of ref document: ES